Authors:
O'Hara, M
Lloyd, WC
Scribbick, FW
Gulley, ML
Citation: M. O'Hara et al., Latent intracellular Epstein-Barr virus DNA demonstrated in ocular posttransplant lymphoproliferative disorder mimicking granulomatous uveitis with iris nodules in a child, J AAPOS, 5(1), 2001, pp. 62-63
Authors:
Ganly, I
Kirn, D
Eckhardt, SG
Rodriguez, GI
Soutar, DS
Otto, R
Robertson, AG
Park, O
Gulley, ML
Heise, C
VonHoff, DD
Kaye, SB
Citation: I. Ganly et al., A phase I study of Onyx-015, an ELB-attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer (vol 6, pg 798, 2000), CLIN CANC R, 7(3), 2001, pp. 754-754
Authors:
Fan, HX
Schichman, SA
Swinnen, LJ
Nicholls, JM
Eagan, PA
Luther, M
Gulley, ML
Citation: Hx. Fan et al., Analytic validation of a competitive polymerase chain reaction assay for measuring Epstein-Barr viral load, DIAGN MOL P, 10(4), 2001, pp. 255-264
Authors:
Macon, WR
Levy, NB
Kurtin, PJ
Salhany, KE
Elkhalifa, MY
Casey, TT
Craig, FE
Vnencak-Jones, CL
Gulley, ML
Park, JP
Cousar, JB
Citation: Wr. Macon et al., Hepatosplenic alpha beta T-cell lymphomas - A report of 14 cases and comparison with hepatosplenic gamma delta T-cell lymphomas, AM J SURG P, 25(3), 2001, pp. 285-296
Authors:
Nicholls, J
Kremmer, E
Meseda, CA
Mackett, M
Hahn, P
Gulley, ML
Brink, A
Swinnen, LJ
Greenspan, J
De Souza, Y
Grasser, F
Sham, J
Ng, MH
Arrand, JR
Citation: J. Nicholls et al., Comparative analysis of the expression of the Epstein-Barr virus (EBV) anti-apoptotic gene BHRF1 in nasopharyngeal carcinoma and EBV-related lymphoiddiseases, J MED VIROL, 65(1), 2001, pp. 105-113
Authors:
Braziel, RM
Arber, DA
Slovak, ML
Gulley, ML
Spier, C
Kjeldsberg, C
Unger, J
Miller, TP
Tubbs, R
Leith, C
Fisher, RI
Grogan, TM
Citation: Rm. Braziel et al., The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features, BLOOD, 97(12), 2001, pp. 3713-3720
Citation: Hb. Jenson et al., Absence of Epstein-Barr virus in smooth muscle cells of idiopathic hypertrophic pyloric stenosis, ARCH PATH L, 125(3), 2001, pp. 361-363
Citation: Ac. Jones et al., Necrotizing ulcerative stomatitis in human immunodeficiency virus-seropositive individuals: A review of the histopathologic, immunohistochemical, andvirologic characteristics of 18 cases, ORAL SURG O, 89(3), 2000, pp. 323-332
Authors:
Ganly, I
Kirn, D
Eckhardt, SG
Rodriguez, GI
Soutar, DS
Otto, R
Robertson, AG
Park, O
Gulley, ML
Heise, C
VonHoff, DD
Kaye, SB
Citation: I. Ganly et al., A Phase I study of Onyx-015, an E1B attenuated adenovirus, administered intramorally to patients with recurrent head and neck cancer (vol 6, pg 798, 2000), CLIN CANC R, 6(9), 2000, pp. 3797-3797
Authors:
Ganly, I
Kirn, D
Eckhardt, SG
Rodriguez, GI
Soutar, DS
Otto, R
Robertson, AG
Park, O
Gulley, ML
Heise, C
Von Hoff, DD
Kaye, SB
Citation: I. Ganly et al., A Phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer, CLIN CANC R, 6(3), 2000, pp. 798-806
Authors:
Schneider, BG
Gulley, ML
Eagan, P
Bravo, JC
Mera, R
Geradts, J
Citation: Bg. Schneider et al., Loss of p16/CDKN2A tumor suppressor protein in gastric adenocarcinoma is associated with Epstein-Barr virus and anatomic location in the body of the stomach, HUMAN PATH, 31(1), 2000, pp. 45-50
Citation: Hx. Fan et Ml. Gulley, Molecular methods for detecting Epstein-Barr virus (part I) - In situ hybridization to Epstein-Barr virus-encoded RNA (EBER) transcripts, METH MOL M, 49, 2000, pp. 301-311
Citation: Hx. Fan et Ml. Gulley, Molecular methods for detecting Epstein-Barr virus (part II) - Structural analysis of Epstein-Barr virus DNA as a marker of clonality, METH MOL M, 49, 2000, pp. 313-319
Citation: Hx. Fan et Ml. Gulley, Molecular methods for detecting Epstein-Barr virus (part III) - EBV viral load by competitive polymerase chain reaction, METH MOL M, 49, 2000, pp. 321-329
Authors:
Mandell, JW
Gulley, ML
Williams, ME
Stoler, MH
Citation: Jw. Mandell et al., Recurrent Epstein-Barr virus-associated post-transplant lymphoproliferative disorder: Report of a patient with histologically similar but clonally distinct metachronous abdominal and brain lesions, HUMAN PATH, 30(10), 1999, pp. 1262-1265
Citation: Jj. Rulon et al., Activated protein C resistance is uncommon in sudden death due to pulmonary embolism, J FOREN SCI, 44(6), 1999, pp. 1111-1113